Cost-effectiveness of Alternative Approaches to Hepatitis C Diagnosis and Treatment Initiation for Treatment-naive People Who Inject Drugs in Australia: A Model-based Economic Evaluation

• by Christopher R Bailie, Nick Scott, Alisa E Pedrana, Margaret E Hellard, Joseph S Doyle

• August 22, 2025

Is Point-of-Care Hepatitis C Virus Testing Too Expensive?

RNA testing carries substantial cost burden for hospitals, study finds

• January 14, 2026

• 2 min

Liver Supplements: Big Sales, Limited Evidence

Researchers evaluate how popular liver cleanse products are formulated and promoted in the US online marketplace.

• by Kathryn Wighton

• January 30, 2026

• 3 min

Integrated Care Models for Hepatitis C: Lessons From Southeast Asia and Sub-Saharan Africa

• by Halder J Abozait, Nawfal R Hussein

• November 10, 2025